SEC Tracker
Get the app

Theriva Biologics TOVX

Theriva Biologics to hold special meeting on Dec 15, 2025

Preliminary proxy statement

Form
PRE 14A
Filed
Importance
Routine
  1. Special meeting to approve issuance of 16,184,560 shares upon warrant exercise
  2. Meeting to be held at 9,605 Medical Center Drive, Suite 270, Rockville, MD
  3. Stockholders of record on Oct 30, 2025, eligible to vote

Written from the PRE 14A on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when Theriva Biologics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Jaguar Health JAGX public float $4M, Jun 30, 2025
  2. Healthy Extracts HYEX public float $4M, Jun 30, 2025
  3. Q/C Technologies QCLS public float $4M, Jun 30, 2025
  4. Polomar Health Services PMHS public float $4M, Jun 30, 2025
  5. Enveric Biosciences ENVB public float $4M, Jun 30, 2025